000			01791 a2200493 4500
005			20250517091500.0
264		0	_c20170321
008			201703s 0 0 eng d
022			_a1878-1705
024	7		_a10.1016/j.intimp.2016.04.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Zhaoguo
245	0	0	_aDexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway. _h[electronic resource]
260			_bInternational immunopharmacology _cJun 2016
300			_a210-216 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenergic alpha-2 Receptor Agonists _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aBungarotoxins _xadministration & dosage
650	0	4	_aDexmedetomidine _xtherapeutic use
650	0	4	_aInterleukin-6 _xgenetics
650	0	4	_aLipopolysaccharides _ximmunology
650	0	4	_aLung _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aPneumonia _xdrug therapy
650	0	4	_aSepsis _xdrug therapy
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Necrosis Factor-alpha _xgenetics
650	0	4	_aalpha7 Nicotinic Acetylcholine Receptor _xantagonists & inhibitors
700	1		_aWang, Yueping
700	1		_aWang, Yaoqi
700	1		_aNing, Qiaoqing
700	1		_aZhang, Yong
700	1		_aGong, Chunzhi
700	1		_aZhao, Wenxiang
700	1		_aJing, Guangjian
700	1		_aWang, Qianqian
773	0		_tInternational immunopharmacology _gvol. 35 _gp. 210-216
856	4	0	_uhttps://doi.org/10.1016/j.intimp.2016.04.003 _zAvailable from publisher's website
999			_c25921462 _d25921462